If a life science company includes people from outside the industry in its board, it can turn into a huge advantage – even if they don't have expert knowledge on the industry, according to business commentator Jens Christian Hansen.
He sees a clear tendency in Tuesday's announcements that Novo Nordisk has nominated Danish utility Ørsted's former President & CEO Henrik Poulsen for its company board at the same as Google's Country Director for Denmark, Malou Aamund, enters WS Audiology's board.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
New CCO at crisis-hit Lundbeck: "2022 will be a growth year for Lundbeck in all regions"
Jacob Tolstrup will be responsible for renewing sales growth at Lundbeck, having made his way through the ranks.
Coloplast upgrades growth expectations following acquisition
Medtech firm Coloplast’s Q1 report for 2021/2022 brings a slight upward adjustment of the reported revenue growth outlook due to foreign exchange developments. Coloplast’s acquisition of Atos Medical is expected to contribute around 6 percent to organic growth.
Demant's surgical division loses president of 13 years
Oticon Medical, the implants division at hearing group Demant, is saying goodbye to President Jes Olsen, who is exiting his role in March after having spearheaded the business leg since 2008. Demant CEO Søren Nielsen is stepping in temporarily until a replacement is found.
Hearing aid market in US grew by 37 percent in 2021
Hearing aid manufacturers have had a good year following one of the worst in their recorded history, as sales in the US have gone up by 37 percent. The progress is mainly driven by the recovery of independent retailers, whereas public sales channel Veterans Affairs still lags behind.
Lundbeck's migraine drug approved in EU
Vyepti has become the first approved intravenous preventative migraine treatment in the region.
Health Economist 
Compound Development Team Lead 
QA Specialist 
Clinical Research Associate 
Senior HR Director, HR Denmark, Ferring 
Director Regulatory Affairs 
GxP QA Compliance Manager for Quality Assurance 
Associate Director, International Medical Affairs 
Director Medical Science 
Project Lead, Muna Therapeutics, Copenhagen, Denmark 
Senior Director, Global Regulatory Lead 
Commercial Excellence Lead 
KLIFO is looking for a Director, Business Support for our Glostrup office 
QA Manager GMP/GDP Compliance & Audits